GlassScriptPhysician profile
Jessica Kwebetchou
NPI 1811885502
$1,355.93
in general payments reported to CMS, 2019-2025
17 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $104 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $404.34 | 2025 | |
| Janssen Biotech, INC. | $208.86 | 2025 | Erleada, Rybrevant, Carvykti |
| Gilead Sciences, INC. | $104.15 | 2024 | |
| Sumitomo Pharma America, INC. | $98.66 | 2025 | Orgovyx |
| Pfizer INC. | $76.14 | 2025 | |
| Progenics Pharmaceuticals, INC. | $72.63 | 2025 | |
| Merck Sharp & Dohme LLC | $71.93 | 2025 | Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $71.17 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $44.84 | 2025 | |
| Astellas Pharma US INC | $43.04 | 2025 | Xtandi |
| Tempus Ai, INC | $28.78 | 2025 | Xt Cdx |
| Blue Earth Diagnostics | $27.36 | 2025 | Posluma |
| Tolmar, INC. | $27.07 | 2025 | Eligard, Jatenzo |
| Novartis Pharmaceuticals Corporation | $20.90 | 2025 | |
| Antares Pharma, INC. | $20.77 | 2025 | Xyosted |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.23 | 2025 | |
| Civco Medical Instruments | $16.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kwebetchou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.